AS Amer Sports

Watchlist

29.905
-0.405-1.34%

Trading Feb 27 10:55 ET

16.52BMarket Cap228.28P/E (TTM)

Amer Sports Key Stats

According to the latest financial report of Amer Sports, the latest earnings per share (TTM) for the company is 0.03. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

FCF

Interested in knowing about Amer Sports's free cash flow? The latest report shows it as 49.20M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Amer Sports shows that the company's current ratio is 1.56, indicating healthy liquidity.

Currency: USD

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Amer Sports, the quick ratio is 0.76, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

ROE

Want to learn more about the financial health of Amer Sports? The latest ROE figure is 0.33%, indicating that the company has stable profitability.

Currency: USD

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Amer Sports, the total asset return on investment (ROA) is 0.18%.

Currency: USD

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Amer Sports's latest financial report to see how their gross margin is doing - currently at 56.10%.

Currency: USD

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Amer Sports, the net profit margin is 1.05%, which is a good sign for its profitability.

Currency: USD

Quarterly

Trending Stocks

Symbol Mini Chart % Chg

Collegium Pharmaceutical

COLL

+1.32%

Halozyme Therapeutics